Latest close: below its 200-day averageSep 8, 2026what changed →
Is the price fair?
What FMS's price assumes
Fresenius Medical Care AG has no trailing P/E on file, so the price is measured against sales instead: 0.33× revenue.
0.33
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 0.48
Price / book · as of 2025-Q4
- EV / sales
- 0.79
EV / sales
Details›
- Price / book2025-Q4
- 0.48
- EV / EBIT2025-Q4
- 8.53
- EV / sales2025-Q4
- 0.79
- Market capitalisation
- $12.5B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.